MREO
Mereo BioPharma
MREO
MREO
16 hedge funds and large institutions have $5.21M invested in Mereo BioPharma in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BC
Birchview Capital
Burlington,
Vermont
|
+$89.3K |
| 2 |
Morgan Stanley
New York
|
+$39.1K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
+$3.14K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.72K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.2K |
